PH12014500544A1 - Dengue-virus serotype neutralizing antibodies - Google Patents

Dengue-virus serotype neutralizing antibodies

Info

Publication number: PH12014500544A1
Authority: PH; Philippines
Prior art keywords: dengue; neutralizing antibodies; virus serotype; serotype neutralizing; virus
Prior art date: 2011-09-09

Application number

PH12014500544A

Other versions

PH12014500544B1 (en

Inventor

NUEGOONPIPAT Atchareeya A-

Surapee Anantapreecha

Panadda Dhepakson

Kazuyoshi Ikuta

Motoki Kuhara

Yoshinobu Okuno

Apichai Prachasuphap

Pongrama Ramasoota

Tadahiro Sasaki

Pathom Sawanpanyalert

Chayanee Setthapramote

Aree Thattiyaphong

Original Assignee

Dept Of Medical Sciences Dmsc

Mahidol Univ

Medical & Biol Lab Co Ltd

Univ Osaka

Univ Osaka Res Found For Microbial Diseases

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-09-09

Filing date

2012-09-07

Publication date

2014-04-21

2012-09-07 Application filed by Dept Of Medical Sciences Dmsc, Mahidol Univ, Medical & Biol Lab Co Ltd, Univ Osaka, Univ Osaka Res Found For Microbial Diseases filed Critical Dept Of Medical Sciences Dmsc

2014-04-21 Publication of PH12014500544A1 publication Critical patent/PH12014500544A1/en

2019-03-13 Publication of PH12014500544B1 publication Critical patent/PH12014500544B1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Health & Medical Sciences (AREA)
Biophysics (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

PH1/2014/500544A 2011-09-09 2012-09-07 Dengue-virus serotype neutralizing antibodies PH12014500544B1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201161532605P	2011-09-09	2011-09-09
US201161532671P	2011-09-09	2011-09-09
PCT/JP2012/005699 WO2013035345A2 (en)	2011-09-09	2012-09-07	Dengue-virus serotype neutralizing antibodies

Publications (2)

Publication Number	Publication Date
PH12014500544A1 true PH12014500544A1 (en)	2014-04-21
PH12014500544B1 PH12014500544B1 (en)	2019-03-13

Family

ID=47116163

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH1/2014/500544A PH12014500544B1 (en)	2011-09-09	2012-09-07	Dengue-virus serotype neutralizing antibodies

Country Status (5)

Country	Link
AU (1)	AU2012305807B2 (en)
MY (1)	MY170725A (en)
PH (1)	PH12014500544B1 (en)
SG (1)	SG11201400100SA (en)
WO (1)	WO2013035345A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6764348B2 (en)	2014-02-11	2020-09-30	ビステラ，インコーポレイテッド	Antibody molecules against dengue virus and their use
CN105137068B (en) *	2015-07-24	2017-03-01	鲁东大学	Florfenicol Site Detection reagent paper and its preparation, using method
CN105004860B (en) *	2015-07-24	2016-09-21	鲁东大学	Florfenicol rapid detection kit and its preparation and use method
WO2017165736A1 (en)	2016-03-25	2017-09-28	Visterra, Inc.	Formulation of antibody molecules to dengue virus
CN109929033B (en) *	2019-03-15	2020-06-02	中国人民解放军军事科学院军事医学研究院	A human antibody that specifically binds four serotypes of dengue virus

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4450150A (en)	1973-05-17	1984-05-22	Arthur D. Little, Inc.	Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US4485045A (en)	1981-07-06	1984-11-27	Research Corporation	Synthetic phosphatidyl cholines useful in forming liposomes
US4741900A (en)	1982-11-16	1988-05-03	Cytogen Corporation	Antibody-metal ion complexes
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US4544545A (en)	1983-06-20	1985-10-01	Trustees University Of Massachusetts	Liposomes containing modified cholesterol for organ targeting
US5169939A (en)	1985-05-21	1992-12-08	Massachusetts Institute Of Technology & Pres. & Fellows Of Harvard College	Chimeric antibodies
GB8800077D0 (en)	1988-01-05	1988-02-10	Ciba Geigy Ag	Novel chimeric antibodies
DE3920358A1 (en)	1989-06-22	1991-01-17	Behringwerke Ag	BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE
US5013556A (en)	1989-10-20	1991-05-07	Liposome Technology, Inc.	Liposomes with enhanced circulation time
US5859205A (en)	1989-12-21	1999-01-12	Celltech Limited	Humanised antibodies
US6800738B1 (en)	1991-06-14	2004-10-05	Genentech, Inc.	Method for making humanized antibodies
CA2078539C (en)	1991-09-18	2005-08-02	Kenya Shitara	Process for producing humanized chimera antibody
EP1136556B1 (en)	1991-11-25	2005-06-08	Enzon, Inc.	Method of producing multivalent antigen-binding proteins
US6042828A (en)	1992-09-07	2000-03-28	Kyowa Hakko Kogyo Co., Ltd.	Humanized antibodies to ganglioside GM2
PT752248E (en)	1992-11-13	2001-01-31	Idec Pharma Corp	THERAPEUTIC APPLICATION OF QUIMERIC ANTIBODIES AND RADIOACTIVELY MARKING OF ANTIGENES OF RESTRICTED DIFFERENTIATION OF HUMAN LYMPHOCYTE B FOR THE TREATMENT OF B-CELL LYMPHOMA
DE4337197C1 (en)	1993-10-30	1994-08-25	Biotest Pharma Gmbh	Process for the selective preparation of hybridoma cell lines which produce monoclonal antibodies with high cytotoxicity against human CD16 antigen, and the preparation of bispecific monoclonal antibodies using such monoclonal antibodies and the CD30-HRS-3 antibody for therapy of human tumours
WO1998047343A2 (en)	1997-04-04	1998-10-29	Biosite Diagnostics, Inc.	Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages
EP1597280B2 (en) *	2003-02-26	2016-08-24	Institute for Research in Biomedicine	Monoclonal antibody production by ebv transformation of b cells
CN101466828B (en) *	2006-04-13	2011-12-21	株式会社医学生物学研究所	Fusion partner cells
EP2144931A2 (en) *	2007-04-04	2010-01-20	The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services	Monoclonal antibodies against dengue and other viruses with deletion in fc region
WO2010043977A2 (en) *	2008-10-13	2010-04-22	Institute For Research In Biomedicine	Dengue virus neutralizing antibodies and uses thereof
WO2010073647A1 (en) *	2008-12-25	2010-07-01	国立大学法人大阪大学	Human anti-human influenza virus antibody
SG173482A1 (en) *	2009-02-10	2011-09-29	Univ Nanyang Tech	Antibodies for diagnosis and treatment of flaviviral infections

2012
- 2012-09-07 PH PH1/2014/500544A patent/PH12014500544B1/en unknown
- 2012-09-07 WO PCT/JP2012/005699 patent/WO2013035345A2/en not_active Ceased
- 2012-09-07 SG SG11201400100SA patent/SG11201400100SA/en unknown
- 2012-09-07 MY MYPI2014700529A patent/MY170725A/en unknown
- 2012-09-07 AU AU2012305807A patent/AU2012305807B2/en active Active

Also Published As

Publication number	Publication date
WO2013035345A2 (en)	2013-03-14
MY170725A (en)	2019-08-27
AU2012305807A8 (en)	2014-03-13
SG11201400100SA (en)	2014-06-27
PH12014500544B1 (en)	2019-03-13
AU2012305807B2 (en)	2015-08-20
WO2013035345A3 (en)	2013-09-06
AU2012305807A1 (en)	2014-02-20

Publication	Publication Date	Title
IL276234B (en)	2022-04-01	Antibody formulations
IL259826A (en)	2018-07-31	Anti-alphabetatcr antibody
IL264558A (en)	2019-02-28	Anti-il-23p19 antibodies
ZA201701051B (en)	2018-05-30	Neutralizing anti-ccl20 antibodies
GB201103955D0 (en)	2011-04-20	Antibodies
GB201112056D0 (en)	2011-08-31	Antibodies
ZA201307983B (en)	2016-01-27	Anti-b7-h3 antibody
IL235042B (en)	2019-05-30	Anti-fcrn antibodies
IL234848A0 (en)	2014-12-31	Protease-regulated antibodies
EP2722343A4 (en)	2014-12-17	ANTI-erbB3 ANTIBODY
IL236259A0 (en)	2015-02-26	Anti-siglec-15 antibodies
SG10201709290XA (en)	2018-01-30	Anti-H7cr Antibodies
TWI563004B (en)	2016-12-21	Anti-hxcr1 antibody
PH12014500544A1 (en)	2014-04-21	Dengue-virus serotype neutralizing antibodies
EP2714074A4 (en)	2015-04-22	Anti-emr1 antibodies
GB201116342D0 (en)	2011-11-02	Antigen combinations
IL235188A0 (en)	2014-12-31	Anti-pdgf-c antibodies